Korn S - Search Results

1

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.

Castro M, Zangrilli J, Wechsler ME, Bateman ED, Brusselle GG, Bardin P, Murphy K, Maspero JF, O'Brien C, Korn S. Castro M, et al. Among authors: korn s. Lancet Respir Med. 2015 May;3(5):355-66. doi: 10.1016/S2213-2600(15)00042-9. Epub 2015 Feb 23. Lancet Respir Med. 2015. PMID: 25736990 Clinical Trial.

2

Discrepant nasal and bronchial nitric oxide kinetics during early and late phase allergic reactions.

Korn S, Beier J, Heilmann C, Kornmann O, Buhl R, Michael Beeh K. Korn S, et al. Respir Med. 2005 Dec;99(12):1595-9. doi: 10.1016/j.rmed.2005.03.029. Epub 2005 Apr 26. Respir Med. 2005. PMID: 16291080 Free article. Clinical Trial.

3

Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week study.

Korn S, Kerwin E, Atis S, Amos C, Owen R, Lassen C; INSIST study group. Korn S, et al. Respir Med. 2011 May;105(5):719-26. doi: 10.1016/j.rmed.2011.02.008. Epub 2011 Mar 1. Respir Med. 2011. PMID: 21367594 Free article. Clinical Trial.

4

Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study.

Korn S, Buhl R. Korn S, et al. Respir Med. 2012 Jan;106(1):57-67. doi: 10.1016/j.rmed.2011.08.010. Epub 2011 Sep 3. Respir Med. 2012. PMID: 21890335 Free article. Clinical Trial.

5

Monitoring free serum IgE in severe asthma patients treated with omalizumab.

Korn S, Haasler I, Fliedner F, Becher G, Strohner P, Staatz A, Taube C, Buhl R. Korn S, et al. Respir Med. 2012 Nov;106(11):1494-500. doi: 10.1016/j.rmed.2012.07.010. Epub 2012 Aug 11. Respir Med. 2012. PMID: 22884459 Free article. Clinical Trial.

6

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, Ortega H, Chanez P. Pavord ID, et al. Among authors: korn s. Lancet. 2012 Aug 18;380(9842):651-9. doi: 10.1016/S0140-6736(12)60988-X. Lancet. 2012. PMID: 22901886 Clinical Trial.

7

Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: the BRIGHT study.

Beeh KM, Korn S, Beier J, Jadayel D, Henley M, D'Andrea P, Banerji D. Beeh KM, et al. Among authors: korn s. Respir Med. 2014 Apr;108(4):584-92. doi: 10.1016/j.rmed.2014.01.006. Epub 2014 Jan 21. Respir Med. 2014. PMID: 24534204 Free article. Clinical Trial.

8

Tiotropium Respimat® in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma.

Beeh KM, Moroni-Zentgraf P, Ablinger O, Hollaenderova Z, Unseld A, Engel M, Korn S. Beeh KM, et al. Among authors: korn s. Respir Res. 2014 Jun 3;15(1):61. doi: 10.1186/1465-9921-15-61. Respir Res. 2014. PMID: 24890738 Free PMC article. Clinical Trial.

9

Mepolizumab treatment in patients with severe eosinophilic asthma.

Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P; MENSA Investigators. Ortega HG, et al. N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199059 Free article. Clinical Trial.

10

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.

Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, Ortega HG, Pavord ID; SIRIUS Investigators. Bel EH, et al. N Engl J Med. 2014 Sep 25;371(13):1189-97. doi: 10.1056/NEJMoa1403291. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199060 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters